{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:27:19Z","timestamp":1793683639314,"version":"4.5.1"},"reference-count":103,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The chronic illness known as diabetes mellitus (DM) is typified by persistently high blood glucose levels or hyperglycemia. Both type 1 and type 2 diabetes, the latter of which is frequently referred to as \u201cadult-onset diabetes\u201d or \u201cinsulin-dependent diabetes,\u201d are progressing conditions with complex and poorly understood etiologies. Often, patients show positive pancreatic beta-cell antibodies, signifying an autoimmune factor. The long-term complications of uncontrolled diabetes are numerous, not just physically based and encompassing everything from kidney failure to foot ulcers and damage to the cardiovascular system, but also with serious neurological disorders, including stroke, amyotrophic lateral sclerosis, Parkinson\u2019s disease, Alzheimer\u2019s disease (AD), and epilepsy. The interplay between neurological disorders and diabetes is complex, and the association of these pathological states in their general description proposes common events, namely oxidative stress, mitochondrial damage, amyloid protein aggregation, glucagon-like peptide-1 secretion skewing, and inflammation. Learning about these interconnections will help us to develop effective strategies for managing both diabetes and its neurological complications.<\/jats:p>","DOI":"10.4103\/ant.ant-d-24-00046","type":"journal-article","created":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:00:14Z","timestamp":1793682014000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Intertwined Threat: How Diabetes Impacts Neurological Disorders \u2013 A Review Article"],"prefix":"10.4103","volume":"35","author":[{"given":"Prajjwal","family":"Rajput","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences and Technology, Baddi, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Jakhar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy and Emerging Sciences, Baddi University of Emerging Sciences and Technology, Baddi, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kashyap","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Bhojia Institute of Dental Sciences, Nalagrah, Himachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Rani","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"R1-20261103","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.3390\/ijms24119328","article-title":"An update on the molecular and cellular basis of pharmacotherapy in type 2 diabetes mellitus","volume":"24","author":"Mahgoub","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R2-20261103","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00109-004-0552-1","article-title":"Neurodegenerative disorders associated with diabetes mellitus","volume":"82","author":"Ristow","year":"2004","journal-title":"J Mol Med (Berl)"},{"key":"R3-20261103","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer's disease: Causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol"},{"key":"R4-20261103","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jphsr\/rmad034","article-title":"Assessing drug utilization and drug-drug interactions in the management of epilepsy, Alzheimer's, Parkinson's disease and migraine","volume":"14","author":"Solanki","year":"2023","journal-title":"J Pharm Health Serv Res"},{"key":"R5-20261103","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/1753-0407.13436","article-title":"The impact of health literacy interventions on glycemic control and self-management outcomes among type 2 diabetes mellitus: A systematic review","volume":"15","author":"Butayeva","year":"2023","journal-title":"J Diabetes"},{"key":"R6-20261103","doi-asserted-by":"crossref","first-page":"842884","DOI":"10.3389\/fsurg.2022.842884","article-title":"Major risk factors analysis of pruritus complicated by type 2 diabetes mellitus and the effect of comprehensive nursing intervention","volume":"9","author":"Yang","year":"2022","journal-title":"Front Surg"},{"key":"R7-20261103","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/s41598-020-64349-x","article-title":"Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles","volume":"10","author":"Rom","year":"2020","journal-title":"Sci Rep"},{"key":"R8-20261103","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/edrv-9-3-346","article-title":"Diabetic complications of the central nervous system","volume":"9","author":"Mooradian","year":"1988","journal-title":"Endocr Rev"},{"key":"R9-20261103","doi-asserted-by":"crossref","first-page":"e21990","DOI":"10.1002\/syn.21990","article-title":"Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration","volume":"71","author":"Rojas-Gutierrez","year":"2017","journal-title":"Synapse"},{"key":"R10-20261103","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fnins.2018.00383","article-title":"Alzheimer's disease and type 2 diabetes: A critical assessment of the shared pathological traits","volume":"12","author":"Chatterjee","year":"2018","journal-title":"Front Neurosci"},{"key":"R11-20261103","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fnagi.2019.00302","article-title":"Diabetes, a contemporary risk for Parkinson's disease: Epidemiological and cellular evidences","volume":"11","author":"Sergi","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"R12-20261103","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/dc10-1333","article-title":"Diabetes and the risk of developing Parkinson's disease in Denmark","volume":"34","author":"Schernhammer","year":"2011","journal-title":"Diabetes Care"},{"key":"R13-20261103","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pathophys.2009.03.003","article-title":"Determination of the extracellular basal levels of glutamate and GABA at dentate gyrus of streptozotocin-induced diabetic rats","volume":"16","author":"Reisi","year":"2009","journal-title":"Pathophysiology"},{"key":"R14-20261103","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00125-005-0123-1","article-title":"Gamma-aminobutyric acid up- and downregulates insulin secretion from beta cells in concert with changes in glucose concentration","volume":"49","author":"Dong","year":"2006","journal-title":"Diabetologia"},{"key":"R15-20261103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13033-015-0031-9","article-title":"Closing the treatment gap for mental, neurological and substance use disorders by strengthening existing health care platforms: Strategies for delivery and integration of evidence-based interventions","volume":"9","author":"Shidhaye","year":"2015","journal-title":"Int J Ment Health Syst"},{"key":"R16-20261103","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/B978-0-444-52902-2.00034-5","article-title":"Biology of diabetic neuropathy","volume":"115","author":"Vincent","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"R17-20261103","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0034-1366278","article-title":"Definition, classification and diagnosis of diabetes mellitus","volume":"122","author":"Kerner","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R18-20261103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2468-8827.184853","article-title":"WHO global report on diabetes: A summary","volume":"1","author":"Roglic","year":"2016","journal-title":"Int J Noncommun Dis"},{"key":"R19-20261103","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12013-015-0598-4","article-title":"Epidemiological perspectives of diabetes","volume":"73","author":"Tao","year":"2015","journal-title":"Cell Biochem Biophys"},{"issue":"Suppl 1","key":"R20-20261103","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"R21-20261103","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"key":"R22-20261103","doi-asserted-by":"crossref","first-page":"e220322202506","DOI":"10.2174\/1573399818666220322095033","article-title":"Chemical constituents based approach for the management of diabetes","volume":"19","author":"Sharma","year":"2023","journal-title":"Curr Diabetes Rev"},{"key":"R24-20261103","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3329\/jpsb.v5i1.23887","article-title":"Diabetes mellitus and gestational diabetes mellitus","volume":"5","author":"Begum","year":"2014","journal-title":"J Paediatr Surg Bangladesh"},{"key":"R25-20261103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"R26-20261103","doi-asserted-by":"crossref","first-page":"1359537","DOI":"10.1155\/2023\/1359537","article-title":"Current Therapeutic Modalities for the Management of Chronic Diabetic Wounds of the Foot","volume":"2023","author":"Oyebode","year":"2023","journal-title":"J Diabetes Res"},{"key":"R27-20261103","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R28-20261103","first-page":"e111","article-title":"Diabetes and its effects: Statistics and biosensors","volume":"2","author":"Kanchi","year":"2015","journal-title":"J Environ Anal Chem"},{"key":"R29-20261103","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/03009734000000056","article-title":"Beta-cell activity and destruction in type 1 diabetes","volume":"105","author":"Karlsson","year":"2000","journal-title":"Ups J Med Sci"},{"key":"R30-20261103","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature06406","article-title":"Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A","volume":"450","author":"Nejentsev","year":"2007","journal-title":"Nature"},{"key":"R32-20261103","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives","volume":"8","author":"Chen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"R33-20261103","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.2741\/3145","article-title":"Regeneration of pancreatic beta cells","volume":"13","author":"Jun","year":"2008","journal-title":"Front Biosci"},{"key":"R34-20261103","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9343(83)90654-X","article-title":"New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus","volume":"74","author":"DeFronzo","year":"1983","journal-title":"Am J Med"},{"key":"R35-20261103","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4172\/2155-6156.1000304","article-title":"Diabetes mellitus type II: Treatment strategies and options: A review","volume":"4","author":"Akram","year":"2013","journal-title":"J Diabetes Metab"},{"key":"R36-20261103","first-page":"3030","article-title":"Diabetes mellitus: An overview","volume":"7","author":"Chaudhary","year":"2018","journal-title":"Int J Res Dev Pharm Life Sci"},{"key":"R38-20261103","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/jp.2008.62","article-title":"Gestational diabetes: Diagnosis and management","volume":"28","author":"Cheng","year":"2008","journal-title":"J Perinatol"},{"key":"R39-20261103","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy: Review articles","volume":"27","author":"Soma Pillay","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"R40-20261103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","article-title":"The role of insulin receptor signaling in the brain","volume":"16","author":"Plum","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R41-20261103","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1155\/NP.2005.311","article-title":"The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease","volume":"12","author":"Messier","year":"2005","journal-title":"Neural Plast"},{"key":"R42-20261103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1872214810666160615102809","article-title":"Alterations in glucose metabolism in Alzheimer's disease","volume":"10","author":"Calsolaro","year":"2016","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"R43-20261103","first-page":"66","article-title":"Insulin and Alzheimer disease: Type 3 diabetes?","volume":"55","author":"Jagua Gualdr\u00f3n","year":"2007","journal-title":"Rev Fac Med"},{"key":"R44-20261103","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3390\/ijms19113306","article-title":"Type 2 diabetes mellitus and Alzheimer's disease: Role of insulin signalling and therapeutic implications","volume":"19","author":"Tumminia","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R45-20261103","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1210\/en.2009-0695","article-title":"Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes","volume":"150","author":"Kim","year":"2009","journal-title":"Endocrinology"},{"key":"R46-20261103","first-page":"83","article-title":"Type 3 Diabetes: Insulin Resistance and Alzheimer's Disease","volume":"21","author":"Calvo Ochoa","year":"2016","journal-title":"Arch Neurociences"},{"key":"R47-20261103","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbadis.2009.09.013","article-title":"Abnormal mitochondrial dynamics and neurodegenerative diseases","volume":"1802","author":"Su","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R48-20261103","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3390\/ijms20102451","article-title":"Mitochondria in neuroprotection by phytochemicals: Bioactive polyphenols modulate mitochondrial apoptosis system, function and structure","volume":"20","author":"Naoi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R49-20261103","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.2174\/1381612811319320005","article-title":"Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases","volume":"19","author":"Fiorentino","year":"2013","journal-title":"Curr Pharm Des"},{"key":"R50-20261103","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/11635890-000000000-00000","article-title":"Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection","volume":"26","author":"H\u00f6lscher","year":"2012","journal-title":"CNS Drugs"},{"key":"R51-20261103","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.3390\/ijms25073812","article-title":"GLP-1 receptor agonists: A new treatment in Parkinson's disease","volume":"25","author":"Kalinderi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R52-20261103","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.peptides.2017.11.017","article-title":"GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes","volume":"100","author":"Gault","year":"2018","journal-title":"Peptides"},{"key":"R53-20261103","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.3390\/nu15204481","article-title":"Cholesterol levels, hormone replacement therapy, and incident dementia among older adult women","volume":"15","author":"Chiu","year":"2023","journal-title":"Nutrients"},{"key":"R54-20261103","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/157340309788166660","article-title":"Lipid raft in cardiac health and disease","volume":"5","author":"Das","year":"2009","journal-title":"Curr Cardiol Rev"},{"key":"R55-20261103","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12944-019-0965-z","article-title":"Role of cholesterol and sphingolipids in brain development and neurological diseases","volume":"18","author":"Hussain","year":"2019","journal-title":"Lipids Health Dis"},{"key":"R56-20261103","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.3390\/nu15143270","article-title":"Cholesterol paradox in older people with type 2 diabetes mellitus regardless of lipid-lowering drug use: A cross-sectional cohort study","volume":"15","author":"Wang","year":"2023","journal-title":"Nutrients"},{"key":"R57-20261103","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.2002.282.1.E1","article-title":"Lipid rafts and insulin signaling","volume":"282","author":"Bickel","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R58-20261103","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/BC20060051","article-title":"Lipid rafts in health and disease","volume":"99","author":"Michel","year":"2007","journal-title":"Biol Cell"},{"key":"R59-20261103","doi-asserted-by":"crossref","first-page":"603052","DOI":"10.4061\/2011\/603052","article-title":"Lipid rafts: Linking Alzheimer's amyloid\u2010\u03b2 production, aggregation, and toxicity at neuronal membranes","volume":"2011","author":"Rushworth","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"R60-20261103","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2741\/4311","article-title":"Amyloid beta-protein and lipid rafts: Focused on biogenesis and catabolism","volume":"20","author":"Araki","year":"2015","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"(1 Suppl)","key":"R61-20261103","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/1474651405005001S0201","article-title":"The role of dyslipidaemia in coronary heart disease","volume":"5","author":"Wierzbicki","year":"2005","journal-title":"Br J Diabetes Vasc Dis"},{"key":"R62-20261103","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1212\/01.wnl.0000279590.22544.c3","article-title":"Lipid rafts, protein scaffolds, and neurologic disease","volume":"69","author":"Benarroch","year":"2007","journal-title":"Neurology"},{"key":"R63-20261103","article-title":"Cognitive Impairments in Alzheimer's Disease and Other Neurodegenerative Diseases","author":"Sohrabi","year":"2019","journal-title":"In Neurodegeneration and Alzheimer's Disease (eds R. N. Martins, C.S. Brennan, W.M.A.D.B. Fernando, M.A. Brennan and S.J. Fuller)"},{"key":"R65-20261103","first-page":"3231","article-title":"The mystery and history of Alzheimer's disease","volume":"14","author":"Parle","year":"2023","journal-title":"Int J Pharm Sci Res"},{"key":"R66-20261103","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.3390\/jcm10194582","article-title":"The clinical and neuropathological features of sporadic (late-onset) and genetic forms of Alzheimer's disease","volume":"10","author":"Rujeedawa","year":"2021","journal-title":"J Clin Med"},{"key":"R67-20261103","first-page":"32","article-title":"Neuropathology of the Alzheimer's continuum: An update","volume":"1","author":"Jellinger","year":"2020","journal-title":"Free Neuropathol"},{"key":"R68-20261103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.9734\/ijbcrr\/2020\/v29i130163","article-title":"The essentials of biochemistry of the proteins as related to Alzheimer's disease: A review","volume":"29","author":"Prasad","year":"2020","journal-title":"Int J Biochem Res Rev"},{"key":"R69-20261103","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer's disease as type 3 diabetes: Common pathophysiological mechanisms between Alzheimer's disease and type 2 diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R70-20261103","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","article-title":"Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders","volume":"67","author":"Profenno","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R71-20261103","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","article-title":"Insulin resistance and neurodegeneration: Progress towards the development of new therapeutics for Alzheimer's disease","volume":"77","author":"de la Monte","year":"2017","journal-title":"Drugs"},{"key":"R72-20261103","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fendo.2014.00161","article-title":"Insulin in the brain: Its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer's disease","volume":"5","author":"Bl\u00e1zquez","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R73-20261103","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2011.02.003","article-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation","volume":"33","author":"Li","year":"2012","journal-title":"Neurobiol Aging"},{"key":"R74-20261103","first-page":"45","article-title":"Type 2 diabetes mellitus, oxidative stress and inflammation: Examining the links","volume":"11","author":"Oguntibeju","year":"2019","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"R75-20261103","doi-asserted-by":"crossref","first-page":"e005819","DOI":"10.1161\/JAHA.117.005819","article-title":"Blood-brain barrier disruption, vascular impairment, and ischemia\/reperfusion damage in diabetic stroke","volume":"6","author":"Venkat","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R76-20261103","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: Review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol Aging"},{"key":"R77-20261103","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jnr.21648","article-title":"ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation","volume":"86","author":"Resende","year":"2008","journal-title":"J Neurosci Res"},{"key":"R78-20261103","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3390\/ijms21082744","article-title":"The interplay between diabetes and Alzheimer's disease-in the hunt for biomarkers","volume":"21","author":"Kubis-Kubiak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R79-20261103","doi-asserted-by":"crossref","first-page":"4981814","DOI":"10.1155\/2020\/4981814","article-title":"Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease","volume":"2020","author":"Sun","year":"2020","journal-title":"J Diabetes Res"},{"key":"R80-20261103","doi-asserted-by":"crossref","first-page":"1192602","DOI":"10.3389\/fendo.2023.1192602","article-title":"Cognitive dysfunction in diabetes: Abnormal glucose metabolic regulation in the brain","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R81-20261103","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/oxfordjournals.aje.a009106","article-title":"Risk of dementia among persons with diabetes mellitus: A population-based cohort study","volume":"145","author":"Leibson","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R82-20261103","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.3233\/JAD-2012-129042","article-title":"Insulin and Alzheimer's disease: Untangling the web","volume":"33","author":"Craft","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"R83-20261103","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3233\/JAD-230555","article-title":"Malignant brain aging: The formidable link between dysregulated signaling through mechanistic target of rapamycin pathways and Alzheimer's disease (type 3 diabetes)","volume":"95","author":"de la Monte","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"R84-20261103","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1093\/hmg\/ddw312","article-title":"Reduced dynamin-related protein 1 protects against phosphorylated tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease","volume":"25","author":"Kandimalla","year":"2016","journal-title":"Hum Mol Genet"},{"key":"R85-20261103","doi-asserted-by":"crossref","first-page":"e823","DOI":"10.1212\/WNL.0000000000006955","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI). Type 2 diabetes mellitus, brain atrophy, and cognitive decline","volume":"92","author":"Moran","year":"2019","journal-title":"Neurology"},{"key":"R86-20261103","doi-asserted-by":"crossref","first-page":"e01725","DOI":"10.1002\/brb3.1725","article-title":"Altered functional connectivity of brain regions based on a meta-analysis in patients with T2DM: A resting-state fMRI study","volume":"10","author":"Zhang","year":"2020","journal-title":"Brain Behav"},{"key":"R87-20261103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/j.jfas.2021.11.003","article-title":"Diabetes-specific dementia: A structured literature review of cognitive assessment methods","volume":"61","author":"Faaitiiti","year":"2022","journal-title":"J Foot Ankle Surg"},{"key":"R88-20261103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bpa.12655","article-title":"Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline","volume":"29","author":"Chornenkyy","year":"2019","journal-title":"Brain Pathol"},{"key":"R89-20261103","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/receptors4010002","article-title":"Exploring the role of GLP-1 receptor agonists in Alzheimer's disease: A review of preclinical and clinical evidence","volume":"4","author":"Teixeira","year":"2025","journal-title":"Receptors"},{"key":"R90-20261103","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fneur.2020.00556","article-title":"Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease\u2014Viewpoint","volume":"11","author":"Sportelli","year":"2020","journal-title":"Front Neurol"},{"key":"R91-20261103","doi-asserted-by":"crossref","first-page":"20190105","DOI":"10.1515\/jbcpp-2019-0105","article-title":"Cognitive impairments in type 2 diabetes, risk factors and preventive strategies","volume":"31","author":"Sharma","year":"2020","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"R92-20261103","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","article-title":"Insulin delivery to the brain via the nasal route: Unraveling the potential for Alzheimer's disease therapy","volume":"14","author":"Wong","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"R93-20261103","first-page":"e42460","article-title":"The application of deep learning to electroencephalograms, magnetic resonance imaging, and implants for the detection of epileptic seizures: A narrative review","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"R94-20261103","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.diabet.2012.02.005","article-title":"Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: Improvement with high-dose intravenous immunoglobulin therapy","volume":"38","author":"Lopez-Sublet","year":"2012","journal-title":"Diabetes Metab"},{"key":"R95-20261103","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2337\/db14-0668","article-title":"GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons","volume":"64","author":"Korol","year":"2015","journal-title":"Diabetes"},{"key":"R96-20261103","doi-asserted-by":"crossref","first-page":"e13081","DOI":"10.14814\/phy2.13081","article-title":"Effects of GABAa receptor antagonists on motor behavior in pharmacological Parkinson's disease model in mice","volume":"5","author":"Mograbi","year":"2017","journal-title":"Physiol Rep"},{"key":"R97-20261103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fncel.2013.00127","article-title":"New mechanism for glutamate hypothesis in epilepsy","volume":"7","author":"Cho","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"R99-20261103","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.bdj.2014.907","article-title":"Diabetes and periodontal disease: A two-way relationship","volume":"217","author":"Casanova","year":"2014","journal-title":"Br Dent J"},{"key":"R100-20261103","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpn.2018.12.006","article-title":"Epilepsy in children with type 1 diabetes mellitus: Pathophysiological basis and clinical hallmarks","volume":"23","author":"Mastrangelo","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"R101-20261103","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: Current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol"},{"key":"R102-20261103","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00125-016-4142-x","article-title":"Type 1 diabetes mellitus and risk of incident epilepsy: A population-based, open-cohort study","volume":"60","author":"Dafoulas","year":"2017","journal-title":"Diabetologia"},{"key":"R103-20261103","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/EJE-12-0699","article-title":"Mechanisms in endocrinology: Seizures and type 1 diabetes mellitus: Current state of knowledge","volume":"167","author":"Verrotti","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"R104-20261103","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/brain\/awaa362","article-title":"The association between systemic autoimmune disorders and epilepsy and its clinical implications","volume":"144","author":"Steriade","year":"2021","journal-title":"Brain"},{"key":"R105-20261103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yebeh.2010.10.006","article-title":"Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: What is their clinical relevance?","volume":"20","author":"Striano","year":"2011","journal-title":"Epilepsy Behav"},{"key":"R106-20261103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1528-1167.2011.03030.x","article-title":"Systemic and neurologic autoimmune disorders associated with seizures or epilepsy","volume":"52","author":"Vincent","year":"2011","journal-title":"Epilepsia"},{"key":"R107-20261103","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/pedi.12346","article-title":"Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies","volume":"17","author":"Ganelin-Cohen","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"R108-20261103","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1073\/pnas.89.20.9841","article-title":"Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes","volume":"89","author":"De Aizpurua","year":"1992","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Acta Neurologica Taiwanica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ant.ANT-D-24-00046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:00:27Z","timestamp":1793682027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ant.ANT-D-24-00046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ant.ant-d-24-00046","relation":{},"ISSN":["1028-768X"],"issn-type":[{"value":"1028-768X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2024-10-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}